AIDS 2012: Adolescent Antiretroviral Options Expanding
- Details
- Category: HIV Treatment
- Published on Tuesday, 14 August 2012 00:00
- Written by Carole Leach-Lemens
A range of new antiretroviral drugs are in development for adolescents with HIV, a population which may have extensive experience with antiretroviral therapy and resistance to some of the most commonly used drugs, researchers reported at the recent XIX International AIDS Conference (AIDS 2012) in Washington, DC. Related presentations covered new treatments for HIV-infected infants and children. 
AIDS 2012: Studies Shed Light on Inflammation and Immune Activation in People with HIV
- Details
- Category: Inflammation & Immune Activation
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
HIV and aging was a major medical themes at the recent XIX International AIDS Conference (AIDS 2012) in Washington, DC. A growing body of evidence indicates that inflammation and excessive immune activation contribute to cardiovascular disease and other non-AIDS conditions in people with HIV as they live to older ages, despite viral suppression on antiretroviral therapy (ART). Several studies presented at the conference looked at the causes and consequences of inflammation in this population. 
AIDS 2012: Aspirin Dampens Immune Activation in HIV+ People on ART
- Details
- Category: Inflammation & Immune Activation
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
Taking a daily aspirin reduces immune activation and activity of platelets -- the cells responsible for blood clotting -- which may help counteract the increased risk of cardiovascular problems among people with HIV taking antiretroviral therapy (ART), researchers reported at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC. 
AIDS 2012: Human Papillomavirus Doubles Risk of HIV infection
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
Pre-existing human papillomavirus (HPV) infection is associated with a 2-fold increase in the risk of HIV acquisition in women, and risk also rose for both heterosexual and gay/bisexual men, according to an 8-study review presented at the recent XIX International AIDS Conference (AIDS 2012) in Washington, DC, and published in the August 7, 2012, advance online edition of AIDS.
AIDS 2012: HPTN 052 Continues to Show Clinical Benefits of Earlier Antiretroviral Therapy
- Details
- Category: When to Start ART?
- Published on Friday, 10 August 2012 00:00
- Written by Liz Highleyman
The HPTN 052 trial, best known for showing that early antiretroviral therapy (ART) can dramatically reduce the risk of HIV transmission within serodiscordant couples, also found that early treatment reduces the risk of clinical events and death, though the benefit was largely driven by extrapulmonary tuberculosis, researchers reported recently at the XIX International AIDS Conference (AIDS 2012) in Washington, DC.
More Articles...
- AIDS 2012: Expanded Access to HIV Treatment Lowered AIDS Deaths Worldwide
- AIDS 2012: Isoniazid Preventive Therapy Reduces Risk of TB for HIV+ People on ART
- AIDS 2012: Black Gay Men Have Higher HIV Rates Despite No Greater Risk Behavior
- AIDS 2012: Why Do Black Gay and Bisexual Men Have Higher HIV Rates? [VIDEO]
Web Design and Development by